SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-24-001009
Filing Date
2024-02-15
Accepted
2024-02-15 11:39:32
Documents
20
Period of Report
2024-02-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT sunshine_8k.htm   iXBRL 8-K 37268
2 UNDERWRITING AGREEMENT sunshine_ex0101.htm EX-1.1 333887
3 FORM OF SERIES A WARRANT sunshine_ex1002.htm EX-4.2 136118
4 FORM OF SERIES B WARRANT sunshine_ex1003.htm EX-4.3 151070
5 PRESS RELEASE DATED FEBRUARY 13, 2024 sunshine_ex9901.htm EX-99.1 10351
6 PRESS RELEASE DATED FEBRUARY 15, 2023 sunshine_ex9902.htm EX-99.2 10990
  Complete submission text file 0001683168-24-001009.txt   1042804

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE sbfm-20240213.xsd EX-101.SCH 3553
8 XBRL DEFINITION FILE sbfm-20240213_def.xml EX-101.DEF 26585
9 XBRL LABEL FILE sbfm-20240213_lab.xml EX-101.LAB 36550
10 XBRL PRESENTATION FILE sbfm-20240213_pre.xml EX-101.PRE 25209
21 EXTRACTED XBRL INSTANCE DOCUMENT sunshine_8k_htm.xml XML 5549
Mailing Address 1177 AVENUE OF THE AMERICAS 5TH FLOOR NEW YORK NY 10036
Business Address 1177 AVENUE OF THE AMERICAS 5TH FLOOR NEW YORK NY 10036 332-216-1147
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41282 | Film No.: 24642829
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)